EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency

Henry H C Lee iD, Itay Tokatly Latzer iD, Mariarita Bertoldi iD, Guangping Gao, Phillip L Pearl iD, Mustafa Sahin iD, Alexander Rotenberg iD

Journal of Inherited Metabolic Disease · 2024-05 · 47 (3) · 476-493

DOI: 10.1002/jimd.12735 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 06.04.2024. Verfasst von Henry H C Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Succinate-Semialdehyde Dehydrogenase, Genetic Therapy, Amino Acid Metabolism, Inborn Errors, Synaptic Transmission. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), NICHD NIH HHS, Translational Research Program (TRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodevelopment is a highly organized and complex process involving lasting and often irreversible changes in the central nervous system. Inherited disorders of neurotransmission (IDNT) are a group of genetic disorders where neurotransmission is primarily affected, resulting in abnormal brain development from early life, manifest as neurodevelopmental disorders and other chronic conditions. In principle, IDNT (particularly those of monogenic causes) are amenable to gene replacement therapy via precise genetic correction. However, practical challenges for gene replacement therapy remain major hurdles for its translation from bench to bedside. We discuss key considerations for the development of gene replacement therapies for IDNT. As an example, we describe our ongoing work on gene replacement therapy for succinic semialdehyde dehydrogenase deficiency, a GABA catabolic disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Succinate-Semialdehyde DehydrogenaseGenetic TherapyAmino Acid Metabolism, Inborn ErrorsSynaptic TransmissionHumansAnimals

Stichwörter der Autor:innen

AAVALDH5A1Dravet syndromeGABAKCC2SLC6A1autosomal dominantautosomal recessivedelivery routedisease modelingepilepsygene expressiongenetic inheritancehaploinsufficiencyneurodevelopment

Substanzen

Succinate-Semialdehyde Dehydrogenase

Autor:innen und Institutionen

  • F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Division of Epilepsy & Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Pediatric Neurology and Child Development Institute, Tel-Aviv University Faculty of Medicine, Tel-Aviv, Israel.
  • Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • The Horae Gene Therapy Center, UMass Medical School, Worcester, Massachusetts, USA.

ORCID-Profile: Henry H C Lee, Itay Tokatly Latzer, Mariarita Bertoldi, Phillip L Pearl, Mustafa Sahin, Alexander Rotenberg

Förderung

  • National Institute of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
  • NICHD NIH HHS
  • Translational Research Program (TRP)
  • NINDS NIH HHS
  • SSADH Association
  • Boston Children's Hospital
  • National Institute of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)
  • BCH

Zitieren

APA

Lee, H. H. C., Latzer, I. T., Bertoldi, M., Gao, G., Pearl, P. L., Sahin, M., & Rotenberg, A. (2024). Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency. Journal of Inherited Metabolic Disease, 47(3), 476-493. https://doi.org/10.1002/jimd.12735

Vancouver

Lee HHC, Latzer IT, Bertoldi M, Gao G, Pearl PL, Sahin M, et al. Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 2024;47(3):476-493. doi:10.1002/jimd.12735

BibTeX
@article{Lee2024,
  author = {Lee, Henry H C and Latzer, Itay Tokatly and Bertoldi, Mariarita and Gao, Guangping and Pearl, Phillip L and Sahin, Mustafa and Rotenberg, Alexander},
  title = {Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  volume = {47},
  number = {3},
  pages = {476--493},
  doi = {10.1002/jimd.12735}
}
Kostenlos starten →